Meet Novartis Management 2020 | Novartis

This annual event gives investors and industry analysts an opportunity to meet with Novartis executives who share deep insights into the company’s growth, pipeline and strategy.

We have delivered strong operational performance over the last three years and are positioned to maintain the momentum. The executives highlighted five assets that are growth drivers in major therapeutic areas, as well as five mid-to-late stage assets in Oncology and six mid-to-late stage assets in Pharmaceuticals with key milestones expected in 2021 and 2022.

We are also taking significant steps to achieve a consistent leadership position in the Environment, Social, Governance (ESG) space as we work to become the leading medicines company powered by data science and advanced therapy platforms.

: Infographic showing progress on the ongoing Novartis transformation and growth strategy

Download the infographic (PDF 0.7 MB)

Media Release

Read the media release

Download the investor presentation (PDF 98 MB)

Event Center

November 24, 2020
14:00 CET – 13:00 GMT – 08:00 EST

Visit the Event Center to watch the webcast

Executive Committee of Novartis (ECN) Biographies

ECN Biographies

Novartis Corporate Fact Sheets

The Corporate Fact Sheets provide a comprehensive overview of Novartis overall as well as our divisions (Innovative Medicines, Sandoz), our research organization NIBR, and outline our commitment to associates as well as Corporate Responsibility.

Read the Corporate Fact Sheets

Follow @NovartisNews

Related links

Environmental, Social and Governance

More:  Novartis post hoc analysis shows high-dose Enerzair® Breezhaler® reduces asthma exacerbations versus medium-dose, complementing key pivotal IRIDIUM study findings

Novartis Global Pipeline

Data and Digital

Diversity & Inclusion

More from: | Category: Pharmaceutical Company News